D. Moga

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Daniela C Moga, D C Moga, D. Moga, Daniela C. Moga, Daniela Claudia Moga, Daniela Moga
Publication record
98 papers · 1,361 citations · H-index 18

PAPERS

Gabapentin initiation and neurocognitive changes in older adults with cognitive impairment
20240 citationsauthor #2
The Association of Gabapentin Initiation with Cognitive and Behavioral Changes in Older Adults with Cognitive Impairment: A Retrospective Cohort Study
20244 citationsauthor #2
Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study
20231 citationsauthor #8
Improvement in Post-traumatic Stress Symptoms Following an Internet-based Cognitive-Behavioral Intervention for Insomnia: An Open Trial among Rural Appalachian Women
20232 citationsauthor #4
Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes
20236 citationsauthor #4
Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology
20239 citationsauthor #17
FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology
202312 citationsauthor #5
359-OR: Variation in Utilization of Continuous Glucose Monitoring in Patients with Type 1 Diabetes
20230 citationsauthor #7
Translation, cultural adaptation and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults.
20233 citationsauthor #11
Association of gabapentin and neuropathological hallmarks in an autopsy cohort of older adults
20230 citationsauthor #2
Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors
20232 citationsauthor #4
Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report
202210 citationsauthor #3
Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists
202214 citationsauthor #6
Evaluation of anemia in communities served by Shoulder to Shoulder Global: a cross-sectional study in Santo Domingo, Ecuador
20221 citationsauthor #2
Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer’s Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression
20225 citationsauthor #1
ISPE‐Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID‐19: Opportunities and Trade‐Offs
202213 citationsauthor #10
Gabapentin utilization among older adults with different cognitive status: Results from the National Alzheimer’s Coordinating Center database (2006‐2019)
20220 citationsauthor #2
The association of gabapentin use and change of cognitive and functional status in older adults with normal cognition
20220 citationsauthor #2
The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition
202224 citationsauthor #2
An evaluation of injurious falls and Fall-Risk-Increasing-Drug (FRID) prescribing in ambulatory care in older adults
20224 citationsauthor #6
Multidisciplinary medication therapy management and participant responses to recommendations: Results from the INCREASE trial
20220 citationsauthor #7
Gabapentin utilization among older adults with different cognitive statuses enrolled in the National Alzheimer's Coordinating Center (2006–2019)
202212 citationsauthor #2
Pharmacoepidemiology and pharmacovigilance
20213 citationsauthor #2
Potentially Inappropriate Medication Use in Older Adults with Alzheimer’s Disease and Related Dementias Living in the Community: A Cross-Sectional Analysis
20216 citationsauthor #5
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools
202111 citationsauthor #7
Does targeted medication therapy management increase cognitive reserve? Results from the INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE) study
20210 citationsauthor #1
Primary care clinician and community pharmacist perceptions of deprescribing
202120 citationsauthor #7
The value of deprescribing in older adults with dementia: a narrative review
202132 citationsauthor #2
Depression Part 3: Medication Related Problems.
20211 citationsauthor #3
Medication Related Problems.
20211 citationsauthor #3
Case Report: The Complexities of Managing Medications and the Importance of Deprescribing Anticholinergics in Older Adults
20214 citationsauthor #3
Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
20210 citationsauthor #7
An investigation of new medications initiation during ambulatory care visits in patients with dementia
20210 citationsauthor #5
An Experimental Education Project for Consultations of Older Adults during the Pandemic and Healthcare Lockdown
202113 citationsauthor #8
INCREASE‐DEPTH: MTM and DEPrescribing THerapy recommendations for medication‐related problems among elderly adults in the INCREASE trial
20210 citationsauthor #9
Medication‐related problems in older adults with and without preclinical Alzheimer’s disease: A baseline description from the INCREASE study
20200 citationsauthor #11
Potentially inappropriate medications that impact cognition are common in older adults with Alzheimer’s disease or related dementias, driven by antipsychotics
20200 citationsauthor #4
Attitudes toward deprescribing in a middle-aged health disparities population.
202015 citationsauthor #6
Potentially inappropriate medication use associated with lower mobility reserve among individuals with preclinical Alzheimer’s disease
20200 citationsauthor #12
Deprescribed anticholinergic medication sustainability among RCT participants
20200 citationsauthor #7
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making
202079 citationsauthor #11
One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults
202010 citationsauthor #7
Potentially inappropriate anticholinergic medication use interacts with memory‐enhancing treatment for patients with Alzheimer’s disease or related dementias
20201 citationsauthor #4
Cognitive reserve for memory performance is mediated by preclinical frontotemporal and limbic amyloid deposition in subjects with normal cognition in early MCI
20200 citationsauthor #2
Cognitive reserve among potentially inappropriate medication users with and without preclinical Alzheimer’s disease
20200 citationsauthor #11
Internet-Based Cognitive Behavioral Therapy for Insomnia in Appalachian Women: A Pilot Study
201917 citationsauthor #4
Determinants of Sleep Medication Use among Participants in the National Alzheimer’s Coordinating Center Uniform Data Set
20191 citationsauthor #3
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol
201916 citationsauthor #1
Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study
201935 citationsauthor #5
P4‐462: INTERVENTION FOR COGNITIVE RESERVE ENHANCEMENT IN DELAYING THE ONSET OF ALZHEIMER'S SYMPTOMATIC EXPRESSION (INCREASE) STUDY‐ PROTOCOL AND BASELINE EVALUATION OF PARTICIPANTS
20191 citationsauthor #1
P2‐572: INAPPROPRIATE MEDICATION USE ASSOCIATED WITH LOWER COGNITIVE RESERVE IN INDIVIDUALS WITH PRE‐CLINICAL ALZHEIMER'S DISEASE
20190 citationsauthor #8
0979 Internet-Based Cognitive Behavioral Therapy for Insomnia in Appalachian Women: A Pilot Study
20190 citationsauthor #4
P2‐589: PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATION USE AND INTERACTIONS IN A PRIVATELY INSURED ELDERLY POPULATION
20180 citationsauthor #3
P1‐514: POTENTIAL IMPACT OF INAPPROPRIATE MEDICATION USE ON PERFORMANCE IN TESTS OF ATTENTION AND EXECUTIVE FUNCTION
20180 citationsauthor #5
P1‐501: PATHOLOGIC ASSOCIATIONS OF POTENTIALLY INAPPROPRIATE MEDICATION USE IN PATIENTS WITH ALZHEIMER'S DISEASE
20180 citationsauthor #6
The effect of Metformin treatment in obese insulin-resistant patients with euthyroid goiter
20185 citationsauthor #5
Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout
201812 citationsauthor #4
The Impact of Dementia Diagnosis on Patterns of Potentially Inappropriate Medication Use Among Older Adults
201831 citationsauthor #4
Statin Use and Gastrointestinal Hemorrhage: A Large Retrospective Cohort Study
201823 citationsauthor #3
Thyroid disorders in obese patients. Does insulin resistance make a difference?
201720 citationsauthor #5
CAN WE IMPROVE MEDICATION USE IN OLDER ADULTS? AN INTERDISCIPLINARY MEDICATION THERAPY INTERVENTION
20170 citationsauthor #1
Bladder antimuscarinics and cognitive decline in elderly patients
201731 citationsauthor #1
An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents
20175 citationsauthor #1
FROM OBSERVATION TO MAKING A CHANGE: ADDRESSING INAPPROPRIATE MEDICATION USE IN OLDER ADULTS
20170 citationsauthor #1
Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden
201747 citationsauthor #1
Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis
201724 citationsauthor #5
Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden
20170 citationsauthor #1
Outcomes after diagnosis of mild cognitive impairment in a large autopsy series
201799 citationsauthor #5
Author ’ s response to reviews Title : An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents Authors :
20170 citationsauthor #1
Dementia for the Primary Care Provider.
201711 citationsauthor #1
ASSOCIATIONS BETWEEN DEMENTIA STATUS AND POLYPHARMACY JOINTLY ACCOUNTING FOR DROPOUT AND DEATH
20170 citationsauthor #3
A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy
20164 citationsauthor #3
Predictors of β-Blocker Initiation After Myocardial Infarction in Patients With Type 2 Diabetes
20160 citationsauthor #3
Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma
20168 citationsauthor #3
National trends in off-label use of atypical antipsychotics in children and adolescents in the United States
201684 citationsauthor #2
A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer’s Disease in the US and Finland
201617 citationsauthor #1
Evaluating the incident-user design in the HIV population: incident-use vs. naive?
20150 citationsauthor #2
Using administrative data for your research project: 10 considerations before you begin.
20153 citationsauthor #3
Dementia and "obesity paradox": is this for real or are we missing something? An epidemiologist's perspective.
201510 citationsauthor #1
Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents
201525 citationsauthor #4
Evaluating the incident user design in the HIV population: incident use versus naive?
20150 citationsauthor #2
Mental disorder comorbidity and in-hospital mortality among patients with acute myocardial infarction
20156 citationsauthor #2
New Practitioners Forum Column Articles in the AJHP
20150 citationsauthor #4
Factors Predicting Beta-Blocker Treatment After Myocardial Infarction In Patients With Type 2 Diabetes
20140 citationsauthor #4
The risk of developing type II diabetes in children and adolescents using atypical antipsychotics
20140 citationsauthor #4
Cost-effectiveness of atypical antipsychotics in attention-deficit/hyperactivity disorder after stimulant failure: A decision analysis
20140 citationsauthor #3
Evaluation of pharmacological management for type-2 diabetes post-myocardial infarction
20130 citationsauthor #1
Automated analysis of retinal images for detection of referable diabetic retinopathy.
2013433 citationsauthor #12
Mental comorbidity and in-hospital mortality among patients with acute myocardial infarction
20130 citationsauthor #2
Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers.
201333 citationsauthor #1
VALIDATION OF TABLET-BASED EVALUATION OF COLOR FUNDUS IMAGES
201223 citationsauthor #2
Bladder antimuscarinics use in the veterans affairs community living centers: description of medication use and evaluation of risks and benefits
20120 citationsauthor #1
Prevalence and characteristics of abnormal head posture in children with Down syndrome: a 20-year retrospective, descriptive review.
201123 citationsauthor #2
Time Series Modelling - Spectrum Analysis
20110 citationsauthor #2
USE OF PHAGE TYPING COMBINED WITH PULSED-FIELD GEL ELECTROPHORESIS AND POLYERASE CHAIN REACTION IN CHARACTERIZATION OF HUMAN SALMONELLA ENTERITIDIS ISOLATES
20080 citationsauthor #3
Age Differences In Pre-Treatment Acute Morbidity In Patients Selected For Chemotherapy For Advanced Lung Cancer In The Cancors Cohort
20080 citationsauthor #1
MOLECULAR AND PHAGE TYPING OF SALMONELLA ISOLATES FROM MAN AND POULTRY IN NORTHWESTERN ROMANIA
20081 citationsauthor #9
Analysis of Some Populational Aspects of Foodborne Disease Outbreaks from Transylvania, Romania, A 10 Years Study
20040 citationsauthor #1

TIMELINE

2004 0 citations

2008 1 citations

2011 23 citations

2012 23 citations

2013 466 citations

2014 0 citations

2015 44 citations

2016 113 citations

2017 237 citations

2018 71 citations

2019 70 citations

2020 105 citations

2021 91 citations

2022 83 citations

2023 35 citations

2024 4 citations

D. Moga

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT